ProCE Banner Activity

CE / CME

Addressing Social Determinants: Strategies to Support PrEP Persistence and Reengagement

Video

Hear from expert faculty in this case-based discussion on the data and recommendations for addressing social determinants as a strategy to support PrEP persistence and engagement for transgender women.

Nurses: 0.25 Nursing contact hour

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Pharmacists: 0.25 contact hour (0.025 CEUs)

Released: November 01, 2023

Expiration: October 31, 2024

Share

Faculty

Beatriz Grinsztejn

Beatriz Grinsztejn, MD, PhD

STI/AIDS Clinical Research Laboratory, Director
Instituto Nacional de Infectologia Evandro Chagas
FIOCRUZ
Rio de Janeiro, Brazil

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, ProCE, LLC, and National Coalition for LGBTQ Health

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

National Coalition for LGBTQ Health

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, nurse practitioners, registered nurses, physician associate/physician assistants, and other healthcare professionals who care for persons at risk of HIV acquisition.

Program Learning Goal

The goal of this program is to equip healthcare professionals caring for patients initiated on PrEP with practical strategies to overcome barriers to PrEP persistence and reengage with those who have discontinued PrEP

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify patients at risk of PrEP discontinuation through proactive monitoring strategies and awareness of populations at increased risk of discontinuation, such as women and younger patients

  • Apply supportive interventions to reduce the risk of inappropriate PrEP discontinuation, addressing health system, regimen-based, and patient factors

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Beatriz Grinsztejn, MD, PhD

STI/AIDS Clinical Research Laboratory, Director
Instituto Nacional de Infectologia Evandro Chagas
FIOCRUZ
Rio de Janeiro, Brazil

Beatriz Grinsztejn, MD, PhD, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC, Practicing Clinicians Exchange, ProCE, LLC, and National Coalition for LGBTQ Health do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from November 01, 2023, through October 31, 2024:

1. Login or Sign Up for an account by clicking at the top of this page.
2. Read the target audience, learning objectives, and faculty disclosures.
3. View and study the content in its entirety.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO), and ProCE, LLC. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hour awarded for this Nursing Continuing Professional Development activity is 0.25 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.25 contact hours (0.025 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008176-9999-23-279-H02-P
Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 65 and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.